Yukichi Takamizawa

  • Citations Per Year
Learn More
We have reviewed the clinical usefulness of tumor markers in gynecologic malignancy. In cervical squamous cell carcinoma. SCC and CEA showed increase in frequency of elevated cases according to the clinical stages (FIGO), and the frequency was significantly higher in recurrent cases than in patients with no evidence of disease. In endometrial carcinoma,(More)
The CA-50 enzyme immunoassay kit (EIA kit) that has been developed with the use of C-50 monoclonal antibody prepared by L. Lindholm et al. was evaluated for diagnosis of human cancer. The levels of CA-50 in the sera were determined using this kit supplied from Mitsui Pharmaceuticals, Inc. Co. in 759 healthy donors, 728 patients with benign disease and 1,263(More)
The choriocarcinoma was one of the most curable malignant neoplasms. This is chiefly because the effective chemotherapy was introduced and the sensitivity of hCG was improved. But about 10-20% cases with choriocarcinoma were drug resistant or recurrent cases. And now, the treatment of these refractory choriocarcinomas were one of the most important clinical(More)
Subclinical Ovarian Vasculitis Developing in a Patient with Rapidly Progressive Glomerulonephritis Associated with Perinuclear Antineutrophil Cytoplasmic Antibody M. Makoto Ogawa N. Naohiko Makino J. Junro Hori S. Shiro Ueda M. Masao Ohto S. Shigeo Isaka Y. Yukichi Takamizawa T. Tetuji Nishikawa B. Bunshiro Akikusa First Department of Internal Medicine,(More)
  • 1